Dalton Media, our fictional publisher, falls from $32 a share at the end of year 1 to $20 at the end of year 3. You see a bargain: perhaps investors have become too pessimistic.
But its annual earnings per share have fallen from $4 to $2.50. The price is lower; so is the profit behind each share.
The old quote tells you where the stock has been. A contrarian case for Dalton needs a reason the future will be better than the price suggests.
Disagree with an expectation
Contrarian investing means taking a researched position against prevailing expectations because you think they have pushed the price too far. That can mean buying an unpopular stock or avoiding a favorite whose price assumes too much growth.
A variant view is your specific disagreement about the business: you expect customers to leave more slowly or earnings to decline less than other investors expect. The business can still be struggling when expectations are too bleak.
Dated analyst forecasts and published research help you identify an expectation to challenge. A falling quote and one gloomy social-media post do not establish a consensus.
The lighter coverage of small caps can leave more room for independent research. It does not establish that the prevailing view is wrong.
Value investing asks whether a business is worth more than its price. The styles overlap, but a low ratio does not prove a stock is unpopular, and an unpopular stock can still be overpriced. Disagreeing with everyone is no substitute for finding something they have missed.
Put Dalton's decline in context
Here are Dalton's reported year-end prices and annual diluted EPS in US dollars. P/E and the changes are calculated from those figures; the price change excludes dividends.
| Measure | FY1 | FY3 | Change |
|---|---|---|---|
| Share price | $32.00 | $20.00 | −37.5% |
| Diluted EPS | $4.00 | $2.50 | −37.5% |
| P/E (times) | 8 | 8 | 0 |
The price change is ($20 − $32) ÷ $32 × 100 = −37.5%. EPS falls by the same proportion.
Dalton still costs $8 for each $1 of annual profit: $32 ÷ $4 in FY1 and $20 ÷ $2.50 in FY3. The lower quote has not made earnings cheaper.
The falling cash flow we saw in the value investigation makes the lower quote harder to defend. Look for a business reason the decline can stabilize; the value-trap checks help separate temporary trouble from lasting damage.
What the research can tell you
In their 1985 study, Werner De Bondt and Richard Thaler found that portfolios of extreme past losers outperformed past winners over the next three years in their main test. They interpreted that reversal as evidence of investor overreaction.
Josef Lakonishok, Andrei Shleifer and Robert Vishny later argued that value opportunities arise when investors project past business trends too far into the future. Investors expect a bad stretch to last too long.
These are historical results for groups of stocks, not a promise about one loser. Researchers debate how much reflects mistaken expectations, extra risk or study design.
Momentum research studied continuation over months; De Bondt and Thaler examined reversals over years. The different horizons help explain why the findings need not conflict. Neither gives you a date to switch strategies.
Build a disagreement that can fail
A thesis connects four claims: “Investors expect ___; I disagree because ___; the business can wait because ___; I am wrong if ___ by ___.”
Dalton's case supplies a benchmark: at FY3, analyst consensus puts next-year diluted EPS at $1.90. That forecast represents analysts, not every investor behind the $20 price.
Suppose the idea you want to test is that next year's EPS will instead hold at FY3's $2.50. The second step remains unanswered.
The evidence would need to come from the business: slowing sales declines, steadier operating margins and cash flow backing the profit. Investor surveys add sentiment context; they do not answer those questions.
Waiting also requires enough cash or financing to meet the company's obligations. Your patience does not pay its bills. If the business fails, common shareholders can lose their entire investment.
An investment catalyst is an event that could change investors' expectations and the share price. An earnings release is one possible catalyst; what it reveals matters more than its place on the calendar. Passing the EPS test alone would not establish a lasting recovery.
Independent does not mean immovable
Treating every further loss as proof that the crowd is wrong turns confirmation bias, the habit of favoring evidence that supports your belief, into a strategy. The price falling again does not make your evidence stronger.
This style asks for research time, money you can leave invested, and a willingness to abandon the idea. It is a poor fit if you need a quick price rise for reassurance. Waiting also uses money and attention that could serve another investment or goal.
For Dalton, the honest research statement is: “The forecast is $1.90. I have no evidence yet for $2.50, and I still need to establish how the business pays its bills until then. I would reject a flat-EPS claim if next year's EPS falls below $2.50. For now, the idea is unproven.”
Sector rotation takes that expectations question from one business to groups of businesses, adding an economic timing decision.
In short
- Being unpopular is not evidence that a stock is mispriced.
- A contrarian thesis names the expectation you dispute and the evidence behind your disagreement.
- Dalton's price and EPS both fall 37.5%, leaving P/E unchanged at 8.
- Independence includes changing your mind when the thesis fails.